Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 79 | 0 | 30 | 0 | €849.60 | €900.00 | 5.932% |
| Biogen Inc. | 58 | 1 | 8 | 0 | €210.80 | €291.35 | 38.209% |
| Vertex Pharmaceuticals Inc. | 57 | 2 | 10 | 0 | €443.05 | €449.52 | 1.461% |
| Boston Scientific | 57 | 0 | 10 | 0 | €70.50 | €76.37 | 8.321% |
| Regeneron Pharmaceuticals Inc. | 51 | 1 | 14 | 0 | €962.20 | €1,046.4 | 8.746% |
| Johnson & Johnson | 44 | 1 | 11 | 0 | €134.24 | €170.00 | 26.639% |
| UnitedHealth Group Inc. | 43 | 1 | 9 | 0 | €450.60 | €538.32 | 19.467% |
| AbbVie Inc. | 41 | 0 | 19 | 0 | €153.50 | €176.30 | 14.854% |
| Thermo Fisher Scientific Inc. | 40 | 0 | 13 | 0 | €496.00 | €565.00 | 13.911% |
| Intuitive Surgical Inc | 38 | 0 | 5 | 0 | €408.30 | €396.68 | -2.847% |
| Novo Nordisk A/S ADR | 38 | 1 | 22 | 0 | €132.00 | €150.00 | 13.636% |
| Pfizer Inc. | 35 | 4 | 8 | 0 | €25.70 | €40.00 | 55.642% |
| Amgen Inc. | 35 | 0 | 11 | 0 | €288.80 | €305.58 | 5.809% |
| Merck & Co. Inc. | 34 | 1 | 5 | 0 | €116.00 | €125.34 | 8.050% |
| HCA Holdings Inc. | 30 | 0 | 4 | 0 | €292.20 | €307.81 | 5.343% |
| Edwards Lifesciences Corp. | 27 | 1 | 0 | 0 | €84.93 | €88.21 | 3.859% |
| Stryker Corp. | 26 | 1 | 2 | 1 | €309.70 | €340.00 | 9.783% |
| Humana Inc. | 24 | 0 | 1 | 0 | €341.00 | €413.82 | 21.355% |
| Zoetis Inc. A | 24 | 1 | 1 | 0 | €163.28 | €198.11 | 21.333% |
| Dexcom Inc. | 23 | 0 | 6 | 0 | €102.76 | €125.00 | 21.643% |
| Gilead Sciences Inc | 23 | 1 | 12 | 0 | €62.00 | €75.00 | 20.968% |
| Bayer AG | 21 | 7 | 7 | 6 | €26.07 | €34.75 | 33.295% |
| Abbott Laboratories | 20 | 0 | 2 | 0 | €94.46 | €115.65 | 22.432% |
| Cigna Corp. | 20 | 0 | 2 | 0 | €295.55 | €351.57 | 18.955% |
| Sanofi S.A. | 20 | 0 | 17 | 0 | €92.25 | €100.00 | 8.401% |